ETHZilla Corporation's latest marketcap:
As of 11/13/2025, ETHZilla Corporation's market capitalization has reached $1.14 B. According to our data, ETHZilla Corporation is the 9507th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 1.14 B |
| Revenue (ttm) | 0 |
| Net Income (ttm) | -17,217,560 |
| Shares Out | 154.03 M |
| EPS (ttm) | -60.25 |
| Forward PE | 0.00 |
| Ex-Dividend Date | n/a |
| Earnings Date | 11/14/2025 |
ETHZilla Corporation's yearly market capitalization.
| Date | Market Cap($) | Change (%) | Global Rank |
|---|---|---|---|
| 11/13/2025 | $1.14 B | 183.33% | 9507 |
| 12/31/2024 | $3.6 M | 125% | n/a |
| 12/29/2023 | $1.6 M | -76.81% | n/a |
| 12/30/2022 | $6.9 M | -94.8% | n/a |
| 12/31/2021 | $132.7 M | 169.72% | n/a |
| 12/31/2020 | $49.2 M | -43.71% | n/a |
| 12/31/2019 | $87.4 M | -42.39% | n/a |
| 12/31/2018 | $151.7 M | 4.98% | n/a |
| 12/29/2017 | $144.5 M | n/a |
Company Profile
180 Life Sciences Corp., originally a clinical-stage biotechnology company, focuses on developing therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases in the United States. In August 2025, the company changed its name to ETHZilla Corporation and shifted its focus to Ethereum asset management and cryptocurrency-related businesses, while retaining its biotechnology R&D background.
The company's product development platforms include the fibrosis and anti-tumor necrosis factor (anti-TNF) platform, which has completed phase 2a and phase 2b proof-of-concept clinical trials for early-stage Dupuytren's Contracture; and the Synthetic Cannabidiol (CBD) Analogs platform, which develops synthetic pharmaceutical-grade molecules that are close or distant analogs of non-psychoactive cannabinoids, such as CBD, for the treatment of inflammatory diseases and pain.
The company is headquartered in Palo Alto, California, USA.
Frequently Asked Questions
-
What is ETHZilla Corporation's (ETHZ) current market cap?As of 11/13/2025, ETHZilla Corporation (including the parent company, if applicable) has an estimated market capitalization of $1.14 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does ETHZilla Corporation (ETHZ) rank globally by market cap?ETHZilla Corporation global market capitalization ranking is approximately 9507 as of 11/13/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.